THULITE Clinical Research Dinner
About this Event
Join us for a complimentary educational dinner sponsored by Boehringer Ingelheim and presented by trial Principal Investigator and Colorado Retina vitreoretinal surgeon, Dr. Frank Siringo.
Designed for optometrists and endocrinologists, this program will provide an overview of emerging retinal disease therapies and clinical research in macular degeneration, diabetic eye disease, and inherited retinal disorders. Attendees will gain insights into current treatment approaches, unmet patient needs, and ongoing research aimed at improving outcomes and reducing treatment burden.
The evening will feature a discussion of the Phase 2 THULITE Trial, a global study now enrolling patients at Colorado Retina, evaluating an investigational oral therapy for Diabetic Macular Edema (DME). Learn how clinical research is advancing new treatment approaches for patients with vision-threatening retinal disease.
The program will be held at Uchiko, Cherry Creek's newest Japanese restaurant, and includes a complimentary multi-course sushi dinner featuring ultra-fresh sushi and signature wood-fired dishes.
- Admission is complimentary.
- Attendance is limited to licensed healthcare providers.
- RSVP required.
- No CE credit provided; program is for educational purposes only.
Disclosure: BI 1815368 is an investigational therapy and has not been approved for safety or efficacy.
Where is it happening?
Event Location & Nearby Stays:
USD 0.00
